The information provided by is not a substitute for professional medical advice,diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of Drugwatch. Sponsored by Wilson and Peterson, LLP with offices at 1 South Orange Ave, Suite 201, Orlando, FL 32801. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: webmaster@
Almost every week, the FDA removes tainted dietary supplements from the market due to health concerns. For example, in January 2016, the FDA issued an alert about “Pink Bikini and Shorts on the Beach Capsules” from Lucy's Weight Loss System of Arlington, TX. It was found that these weight loss aids contained sibutramine, phenolphthalein, and/or diclofenac, but these ingredients were not declared on the label. Sibutramine can cause increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Phenolphthalein was previously used in over-the-counter (OTC) laxatives, but was removed from the US market. Health risks linked to phenolphthalein could include potentially serious stomach upset, irregular heartbeat, and cancer with long-term use. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) which could lead to serious side effects in patients taking other NSAIDs, with recent heart surgery, or with allergies to NSAIDs. NSAIDs can also lead to stomach bleeding, fatal heart attack or stroke.